Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Monoclonal gammapathies.

G Merlini1, F Aguzzi, J Whicher

  • 1Biotechnology Research Laboratories, University Hospital IRCCS Policlinico S. Matteo, Pavia, Italy.

Journal of the International Federation of Clinical Chemistry
|November 3, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early data on long-term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2-year update from the open-label extension of the NEURO-TTR trial.

European journal of neurology·2020
Same author

Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel.

Journal of hematology & oncology·2018
Same author

Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma.

Leukemia·2016
Same author

Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis.

Leukemia·2016
Same author

Mechanisms in chronic inflammation.

Immunology today·2014
Same author

Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case-control study on 174 patients.

Leukemia·2014
Same journal

The significance of the International Normalized Ratio (INR) for oral anticoagulant therapy.

Journal of the International Federation of Clinical Chemistry·2010
Same journal

Magnetic resonance spectroscopy in clinical chemistry: the present and the future.

Journal of the International Federation of Clinical Chemistry·1998
Same journal

Aging and oxidative stress.

Journal of the International Federation of Clinical Chemistry·1998
Same journal

Use of antioxidants in the prevention and treatment of disease.

Journal of the International Federation of Clinical Chemistry·1998
Same journal

Methods for detection of point mutations: performance and quality assessment. The IFCC Scientific Division, Committee on Molecular Biology Techniques.

Journal of the International Federation of Clinical Chemistry·1997
Same journal

Single-strand conformation polymorphism analysis with high throughput modifications, and its use in mutation detection in familial hypercholesterolemia. The IFCC Scientific Division: Committee on Molecular Biology Techniques.

Journal of the International Federation of Clinical Chemistry·1997
See all related articles

Monoclonal gammapathies (MG) involve abnormal B cell clones producing monoclonal immunoglobulins. Clinical laboratories detect these monoclonal components, aiding diagnosis and management of silent or overt conditions.

Area of Science:

  • Clinical Chemistry
  • Immunology
  • Hematology

Background:

  • Monoclonal gammapathies (MG) are characterized by monoclonal immunoglobulin (MC) production from a B cell clone.
  • MG can be clinically silent or manifest as overt disease due to clone proliferation or organ damage.
  • Clinical laboratories play a crucial role in diagnosing and managing MG.

Purpose of the Study:

  • To highlight the significance of monoclonal immunoglobulin detection in diagnosing and managing monoclonal gammapathies.
  • To emphasize the role of clinical laboratorians in identifying monoclonal components.
  • To underscore the utility of monoclonal immunoglobulin as a tumor marker.

Main Methods:

  • Detection and quantitation of monoclonal immunoglobulin (MC) in serum and/or urine.

Related Experiment Videos

  • Analysis of immunoglobulin subunits, heavy chains, and light chains.
  • Laboratory assessment for B cell clone-produced proteins.

    • Main Results:

    • Monoclonal immunoglobulins are key indicators for characterizing monoclonal gammapathies.
    • Detection of MC aids in differentiating between silent MG and clinically overt conditions.
    • Quantitation of MC serves as a valuable tumor marker for disease management.

    Conclusions:

    • The detection and quantitation of monoclonal immunoglobulins are essential for the diagnosis and management of monoclonal gammapathies.
    • Clinical laboratory findings are critical for identifying patients with MG and monitoring disease progression.
    • Monoclonal immunoglobulin serves as an effective tumor marker in the context of monoclonal gammapathies.